Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Since Baylen Out Loud premiered on TLC in January 2025, Tourette syndrome advocate Baylen Dupree has gained even more social ...

Baylen Out Loud star Baylen Dupree has given fans a close-up glimpse at her engagement ring from fiancé Colin Dooley. The TLC ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...

In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Baylen Dupree was interviewed on the 'Not Skinny But Not Fat' podcast on Feb. 19 and revealed she doesn't get tics when she's ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

TLC’s breakout series, Baylen Out Loud, is getting a second season, per a recent press release from the network. The series ...